Regina Demlova

The concept of “CZECRIN disease-oriented networks” at national level

Robert Mikulík

Presentation of the national ict research network STROCZECH

Zuzana Motovská

Presentation of the national research network CARDIO

Radka Obermannová

Presentation of the ONCO National Research Network – cross-cutting activities

Jiří Mayer

Presentation of the national research network HEMATO-ONCO

Jiří Deml

Regulatory and strategic support for CZECRIN in clinical research

Leoš Ševčík

Risk management in clinical trials from a quality manager’s perspective

Katerina Nebeska

KH registries and transparency of clinical trial data

Jana Vinklerová

5 basic tips when preparing KH – what to watch out for when implementing KH

Jiří Deml

CZECRIN Open Access principles and availability of services

Jana Vinklerová

The process of requesting cooperation with VVI CZECRIN and an overview of the use of VVI CZECRIN services

Kristýna Nosková

ECRIN-ERIC application process

Jitka Rychlíčková

RIS database – regulatory information in one place

Martina Štorová

Clinical data management and its importance in clinical trials

Irena Koutná

Development and research of MSC-based ATMPs

Abanoud Riad

CoVaST: Covid-19 Vaccines Safety Tracking

Jiří Škopek

Academic clinical trials organized by Thomayer Hospital: NORMOSANG, IMMUNOR

Jan Maláska

REMED

Michal Rezek

IVER-FNUSA

Karolína Grodová

CoVigi

Filip Tylš, Tomáš Páleníček

Psychedelic-assisted therapy in the treatment of persistent depression and depression in existential crisis in cancer patients – clinical trials PSIKET001 and PSIKET002

Lenka Zdražilová Dubská

ATMP development and research for clinical trials

Šárka Kozáková

TDM in sunitinib + KH Protocol Design

Katarina Kostolanská

Development of an LC-MS method for TKI quantification

Adam Svobodnik

Design and methodology of N-of-1 trials

Lenka Součková

Investigator-Initiated Clinical Trials (IICT): a comparison of the Czech Republic and Portugal in terms of funding policy and scientific results